| Entry |
|
|---|
| Name |
Siplizumab (USAN/INN) |
|---|
| Efficacy |
Immunosuppressant, Anti-CD2 antibody |
|---|
| Type |
Monoclonal antibody |
|---|
| Comment |
Treatment of auto-immune diseases / immune disorders
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
Cell surface molecules and ligands
Cell adhesion molecules: Ig superfamiy
CD2 family
CD2
D05847 Siplizumab (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
